These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 16598310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
    Aslan DL, Peterson BA, Long-Tsai M, Eastlund T.
    Transfusion; 2006 Jan; 46(1):90-4. PubMed ID: 16398735
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Autoimmune hemolytic anemia with warm antibodies complicated with an intercurrent attack of hemolysis with cold agglutinins in a case of Waldenström disease.
    Gologan R, Dima I, Butoianu E, Nicoară S, Coliţă D.
    Rom J Intern Med; 1996 Jan; 34(1-2):149-54. PubMed ID: 8908641
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and immunological problems in autoimmune hemolytic anemias].
    Bernasconi C, Lazzarino M, Pontiggia P.
    Haematologica; 1970 Jan; 55(1):1-48. PubMed ID: 4101018
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Waldenström's macroglobulinemia with preserved antierythrocyte and antilipoprotein antibody activity].
    Zittoun R, Beaumont JL, Homberg JC, Carbonniere C, Debre P, Bousser J.
    Sem Hop; 1975 Dec 09; 51(48):2943-8. PubMed ID: 175506
    [Abstract] [Full Text] [Related]

  • 9. Attainment of complete/very good partial response following rituximab-based therapy is an important determinant to progression-free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemia.
    Treon SP, Yang G, Hanzis C, Ioakimidis L, Verselis SJ, Fox EA, Xu L, Hunter ZR, Tseng H, Manning RJ, Patterson CJ, Sheehy P, Turnbull B.
    Br J Haematol; 2011 Jul 09; 154(2):223-8. PubMed ID: 21564078
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new red blood cell cold autoantibody (anti-Me).
    Salama A, Pralle H, Mueller-Eckhardt C.
    Vox Sang; 1985 Jul 09; 49(4):277-84. PubMed ID: 3933180
    [Abstract] [Full Text] [Related]

  • 15. [Immunological characteristics of autoimmune hemolytic anemia associated with warm antierythrocyte antibodies].
    Amirkhanian ES, Idel'son LI.
    Probl Gematol Pereliv Krovi; 1973 Aug 09; 18(8):40-5. PubMed ID: 4781505
    [No Abstract] [Full Text] [Related]

  • 16. Allotypic and isotypic determination of auto-antibodies in IgG haemolytic anemias.
    Le Petit JC, Brizard CP.
    Nouv Rev Fr Hematol; 1971 Aug 09; 11(2):255-60. PubMed ID: 4252678
    [No Abstract] [Full Text] [Related]

  • 17. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn].
    Lynen R, Neuhaus R, Simson G, Riggert J, Köhler M.
    Beitr Infusionsther Transfusionsmed; 1994 Aug 09; 32():203-7. PubMed ID: 9480088
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients.
    Tamburini J, Lévy V, Chaleteix C, Fermand JP, Delmer A, Stalniewicz L, Morel P, Dreyfus F, Grange MJ, Christian B, Choquet S, Leblond V.
    Leukemia; 2005 Oct 09; 19(10):1831-4. PubMed ID: 16121217
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.